Open access
Open access
Powered by Google Translator Translator

Daily Archives: July 1, 2022

2022 Guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.

1 Jul, 2022 | 11:50h | UTC

2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 – The Lancet Oncology

Related:

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy – Cochrane Library

American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer – Blood Advances

Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network

Venous and Arterial Thromboembolism in Patients With Cancer: JACC: CardioOncology State-of-the-Art Review

 


Two new studies show no benefit of Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19.

1 Jul, 2022 | 11:49h | UTC

Study 1: Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial – The Lancet Haematology

Study 2: Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial – The Lancet Haematology

Commentaries:

Antithrombotic prophylaxis for symptomatic outpatients with COVID-19: less is consistently more – The Lancet Haematology

Antithrombotic Prophylaxis No Help in Outpatients With COVID — Two trials show no differences between patients who received enoxaparin vs standard of care – MedPage Today (free registration required)

 

Commentary on Twitter (thread – click for more)

 


Systematic Review: Mobility training for increasing mobility and functioning in older people with frailty.

1 Jul, 2022 | 11:41h | UTC

Mobility training for increasing mobility and functioning in older people with frailty – Cochrane Library

Summary: Mobility training for increasing mobility and functioning in older people who are frail – Cochrane Library

 


RCT: A single immediate dose of intravenous tenecteplase is noninferior to alteplase for the treatment of patients with acute ischemic stroke.

1 Jul, 2022 | 11:44h | UTC

Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial – The Lancet (link to abstract – $ for full-text)

News Release: UCalgary researchers with the Calgary Stroke Program make another breakthrough in the treatment of stroke

 


Accuracy of rapid antigen vs. RT-PCR testing for SARS-CoV-2 infection in college athletes during prevalence of the Omicron variant.

1 Jul, 2022 | 11:39h | UTC

Accuracy of Rapid Antigen vs Reverse Transcriptase–Polymerase Chain Reaction Testing for SARS-CoV-2 Infection in College Athletes During Prevalence of the Omicron Variant – JAMA Network Open

 

Commentary on Twitter

 


Consensus Statement: Definition, diagnosis, and clinical management of non-obstructive kidney dysplasia.

1 Jul, 2022 | 11:36h | UTC

Definition, diagnosis, and clinical management of non-obstructive kidney dysplasia: a consensus statement by the ERKNet working group on Kidney Malformations – Nephrology Dialysis Transplantation

 


UEG and EAES rapid guideline on transanal total mesorectal excision for rectal cancer.

1 Jul, 2022 | 11:33h | UTC

UEG and EAES rapid guideline: Systematic review, meta-analysis, GRADE assessment and evidence-informed European recommendations on TaTME for rectal cancer – Surgical Endoscopy

 


Cohort Study: Effectiveness of Pfizer, Moderna, and AstraZeneca vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting.

1 Jul, 2022 | 11:37h | UTC

Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study – BMJ Medicine

 

Commentary on Twitter

 


Consensus for the definition, classification, diagnosis, and management of urticaria.

1 Jul, 2022 | 11:32h | UTC

Taiwanese dermatological association consensus for the definition, classification, diagnosis, and management of urticaria: A 2021 update – Journal of the Formosan Medical Association

 


Echocardiographic guidance in transcatheter structural cardiac interventions.

1 Jul, 2022 | 11:28h | UTC

Echocardiographic guidance in transcatheter structural cardiac interventions – EuroIntervention

 

Commentary on Twitter

 


Spanish guide for neonatal stabilization and resuscitation.

1 Jul, 2022 | 11:24h | UTC

Spanish guide for neonatal stabilization and resuscitation 2021 – Anales de Pediatría (English Edition)

 


Cohort Study: B‐Type Natriuretic Peptide and long‐term cardiovascular mortality in patients with coronary heart disease.

1 Jul, 2022 | 11:04h | UTC

B‐Type Natriuretic Peptide and Long‐Term Cardiovascular Mortality in Patients With Coronary Heart Disease – Journal of the American Heart Association

 


Systematic Review: Certolizumab pegol for maintenance of medically induced remission in Crohn’s disease.

1 Jul, 2022 | 11:22h | UTC

Certolizumab pegol for maintenance of medically induced remission in Crohn’s disease – Cochrane Library

Summary: Certolizumab pegol for the treatment of maintaining inactive Crohn’s disease – Cochrane Library

 


Cohort Study: Association of posttraumatic stress disorder with accelerated cognitive decline in middle-aged women.

1 Jul, 2022 | 11:21h | UTC

Association of Posttraumatic Stress Disorder With Accelerated Cognitive Decline in Middle-aged Women – JAMA Network Open

 

Commentary on Twitter

 


Case-Control Study: Accuracy of chest CT in distinguishing cystic pleuropulmonary blastoma from benign congenital lung malformations in children.

1 Jul, 2022 | 11:02h | UTC

Accuracy of Chest Computed Tomography in Distinguishing Cystic Pleuropulmonary Blastoma From Benign Congenital Lung Malformations in Children – JAMA Network Open

Invited Commentary: Can Computed Tomography Scans Reliably Distinguish Pleuropulmonary Blastoma From Congenital Lung Malformations? – JAMA Network Open

 

Commentary on Twitter

 


RCT: Oxaliplatin (3 months vs. 6 months) with 6 months of Fluoropyrimidine as adjuvant therapy in patients with stage II/III colon cancer.

1 Jul, 2022 | 10:59h | UTC

Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07 – Journal of Clinical Oncology

Related Study: Final Analysis of 3 Versus 6 Months of Adjuvant Oxaliplatin and Fluoropyrimidine-Based Therapy in Patients With Stage III Colon Cancer: The Randomized Phase III ACHIEVE Trial – Journal of Clinical Oncology

 


RCT: Effect of a community health worker intervention on acute care use, advance care planning, and patient-reported outcomes among adults with advanced stages of cancer.

1 Jul, 2022 | 10:58h | UTC

Effect of a Community Health Worker Intervention on Acute Care Use, Advance Care Planning, and Patient-Reported Outcomes Among Adults With Advanced Stages of Cancer: A Randomized Clinical Trial – JAMA Oncology (free for a limited period)

See also: Visual Abstract

 


RCT: The effect of enhanced recovery after minimally invasive esophagectomy.

1 Jul, 2022 | 10:56h | UTC

The effect of enhanced recovery after minimally invasive esophagectomy: a randomized controlled trial – Surgical Endoscopy

Related:

Guidelines for Perioperative Care in Esophagectomy: Enhanced Recovery After Surgery (ERAS®) Society Recommendations – World Journal of Surgery

Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines

Top 100 Most-Cited Articles on Enhanced Recovery After Surgery: A Bibliometric Analysis and Visualized Study – Frontiers in Surgery

Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: ERAS and Oesophagectomy – Annals of Surgical Oncology

Visual abstract: ASO Visual Abstract: Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery—ERAS and Esophagectomy

Enhanced recovery after surgery (ERAS) programs for esophagectomy – Journal of Thoracic Disease

 


RCT: Diclofenac–hyaluronate conjugate intra-articular injection for hip, ankle, shoulder, and elbow osteoarthritis.

1 Jul, 2022 | 10:55h | UTC

Diclofenac–hyaluronate conjugate (diclofenac etalhyaluronate) intra-articular injection for hip, ankle, shoulder, and elbow osteoarthritis: a randomized controlled trial – BMC Musculoskeletal Disorders

 


RCT: FODMAP diet vs. medication in primary care patients with irritable bowel syndrome.

1 Jul, 2022 | 10:46h | UTC

Diet or medication in primary care patients with IBS: the DOMINO study – a randomised trial supported by the Belgian Health Care Knowledge Centre (KCE Trials Programme) and the Rome Foundation Research Institute – Gut (link to abstract – $ for full-text)

 


Review: Nutrition management for critically ill adult patients requiring non-invasive ventilation.

1 Jul, 2022 | 10:42h | UTC

Nutrition Management for Critically Ill Adult Patients Requiring Non-Invasive Ventilation: A Scoping Review – Nutrients

 


Safety of empagliflozin in patients with Type 2 Diabetes and chronic kidney disease: pooled analysis of placebo-controlled clinical trials.

1 Jul, 2022 | 10:44h | UTC

Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials – Diabetes Care

 


Review: Lassa Virus Infection.

1 Jul, 2022 | 10:38h | UTC

Lassa Virus Infection: a Summary for Clinicians – International Journal of Infectious Diseases

 


Brief Review: Point-of-care ultrasound for critically-ill patients.

1 Jul, 2022 | 10:41h | UTC

Point-of-care ultrasound for critically-ill patients: A mini-review of key diagnostic features and protocols – World Journal of Critical Care Medicine

 


RCT: Effect of Apatinib plus Pegylated Liposomal Doxorubicin vs. Pegylated Liposomal Doxorubicin alone on platinum-resistant recurrent ovarian cancer.

1 Jul, 2022 | 10:37h | UTC

Effect of Apatinib Plus Pegylated Liposomal Doxorubicin vs Pegylated Liposomal Doxorubicin Alone on Platinum-Resistant Recurrent Ovarian Cancer: The APPROVE Randomized Clinical Trial – JAMA Oncology

See also: Visual Abstract

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.